- On Announcement of All Oral MDR TB regimen by Indian Government
- Modi visit to US: Trump appearance signals importance of India
- After ‘Howdy Modi’, Trump and Modi likely to sign trade deal
- US – India Relations: President Trump To Sign New Trade Deal With Indian PM Modi?
- India-US trade talks: Trading lives?
Category Archives: Sofosbuvir
Source: http://www.makemedicinesaffordable.org The Ministry of Economic Development and Trade of Ukraine (MEDT) refused to grant the pharmaceutical company Gilead a patent for hepatitis C drug sofosbuvir. On 2 March 2018, the MEDT issued the order (No. 305) which approved the … Continue reading
Argentina has made an important step forward to protect local production of generics of an essential medicine to treat Hepatitis C. This brings significant advantages for Public Programs which procure the medicines. Buenos Aires, December 4, 2017. In Argentina, the … Continue reading
By Divya Rajagopal, The Economic Times | May 23, 2017 MUMBAI: Remember Ron the rodeo cowboy from the Oscar-winning film Dallas Buyers Club? The biopic portrayed the story of Ron Woodroof, an AIDS patient in the mid-1980s who signed up … Continue reading
A health advocacy group voiced its opposition Tuesday to a patent application for hepatitis C medicine, Sofosbuvir, filed with the Department of Intellectual Property’s Patent Office, which the group said was unjustified. If approved, the drug patent would bar fair … Continue reading
Source: Business World The patent challenges could remove barriers to production and distribution of affordable generic versions of direct-acting antiviral medicines, which are currently sold at very high prices Patient and healthcare aid groups, including I-MAK and Delhi Network of … Continue reading
By Rupali Mukherjee, The Times of India MUMBAI: Healthcare aid and patient groups have come together in patent courts to fight against “abusive strategies” of Big Pharma, to ensure access to affordable treatment in hepatitis C. The Initiative for Medicines, … Continue reading